Pine Labs Stock Slides 45% From Peak as Analysts Warn
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Pine Labs debuted on Indian stock exchanges on November 14, 2025 at a 10% premium over its IPO price and later hit a high of Rs 284 (29% above issue price) before sliding 45% from that peak and trading 29% below the IPO price.
- Pine Labs posted a consolidated net profit of Rs 42 crore in Q3FY26 versus a loss of Rs 57 crore in the year-ago period, with revenue from operations rising 24% year-on-year to Rs 744 crore.
- Pine Labs profits jumped 600% sequentially from Rs 6 crore in Q2FY26, yet the stock has still declined 35% in 2026, with the steepest single-month sell-off of 18% coming in March during the peak of the Iran-Israel war.
- Kranthi Bathini, Director-Equity Strategy at WealthMills Securities, attributed the slide to "dying euphoria" in domestic primary markets, noting NSE data shows 133 of 219 IPOs over the past year now trade below their issue price, including 82 with listing-day losses.
- Dr. Ravi Singh of Master Capital Services said the chart shows a clear downtrend with lower highs and lower lows, warning that if the stock breaks below 150, it could drift toward the 130 zone, and that fresh buying should be avoided until it sustains above 174.
- Nilesh Jain of Centrum Finverse recommended investors "avoid" the stock, while Bathini said the valuation remains "elevated" and advised watching the next few quarters before taking a position.
Why it matters: Pine Labs' 45% slide from peak despite a 600% sequential profit jump and a return to net profitability shows the decoupling of fundamentals from share price in India's IPO market. With 133 of the past year's 219 IPOs now trading below issue price, brokerages are urging caution on the stock's "elevated" valuation and signaling that listing-day premiums no longer protect retail investors.
